Liver transplantation for hepatocellular carcinoma: are international guidelines possible?
作者信息
Hshieh Tammy T, Sundaram Vinay
机构信息
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, USA;
Department of Medicine and Transplant Institute, Loma Linda University Medical Center, Loma Linda Medical School, USA.
出版信息
Hepatobiliary Surg Nutr. 2013 Apr;2(2):113-6. doi: 10.3978/j.issn.2304-3881.2012.10.03.
Abstract
摘要
相似文献
1
Liver transplantation for hepatocellular carcinoma: are international guidelines possible?肝细胞癌的肝移植：国际指南可行吗？
Hepatobiliary Surg Nutr. 2013 Apr;2(2):113-6. doi: 10.3978/j.issn.2304-3881.2012.10.03.
2
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group.临床实践中遵循美国肝病研究学会肝细胞癌治疗指南：博洛尼亚肝脏肿瘤学组的经验
Dig Liver Dis. 2014 Jun;46(6):549-55. doi: 10.1016/j.dld.2014.02.012. Epub 2014 Mar 14.
3
Liver transplantation for hepatocellular carcinoma: Where do we stand?肝移植治疗肝细胞癌：我们处于什么位置？
World J Gastroenterol. 2019 Jun 7;25(21):2591-2602. doi: 10.3748/wjg.v25.i21.2591.
4
Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines.健康肝脏和肝硬化肝脏中肝细胞癌的手术治疗有标准吗？八项指南的比较。
BMJ Open Gastroenterol. 2017 Mar 24;4(1):e000129. doi: 10.1136/bmjgast-2016-000129. eCollection 2017.
5
Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group.术前TNM分期对于肝移植后肝细胞癌复发来说，是比外周血白蛋白mRNA更好的预后指标。肝移植肿瘤学组。
J Hepatol. 1998 Mar;28(3):497-503. doi: 10.1016/s0168-8278(98)80325-5.
6
Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.非酒精性脂肪性肝炎相关肝细胞癌患者的肝移植
Clin Gastroenterol Hepatol. 2009 Jul;7(7):800-6. doi: 10.1016/j.cgh.2009.02.025. Epub 2009 Mar 9.
7
Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.钆塞酸增强肝脏磁共振成像在检测 HCC 和根据米兰标准和 UNOS 指南分配肝移植受者中的诊断性能：与组织病理学发现的相关性。
Radiology. 2015 Jan;274(1):149-60. doi: 10.1148/radiol.14140141. Epub 2014 Sep 5.
8
Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.超出米兰标准的肝细胞癌肝移植
Exp Clin Transplant. 2017 Mar;15(Suppl 2):59-64. doi: 10.6002/ect.TOND16.L16.
9
Liver transplantation for hepatocellular carcinoma: current update on treatment and allocation.肝细胞癌的肝移植：治疗与分配的最新进展
Curr Opin Organ Transplant. 2017 Apr;22(2):128-134. doi: 10.1097/MOT.0000000000000385.
10
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.甲胎蛋白在肝细胞癌肝移植中的作用
World J Hepatol. 2016 Jul 28;8(21):881-90. doi: 10.4254/wjh.v8.i21.881.
引用本文的文献
1
Recent advances in computerized imaging and its vital roles in liver disease diagnosis, preoperative planning, and interventional liver surgery: A review.计算机成像技术的最新进展及其在肝脏疾病诊断、术前规划和肝脏介入手术中的重要作用：综述
World J Gastrointest Surg. 2023 Nov 27;15(11):2382-2397. doi: 10.4240/wjgs.v15.i11.2382.
本文引用的文献
1
Is the treatment of hepatocellular carcinoma on the waiting list necessary?等待名单上的肝细胞癌患者是否需要治疗？
Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391.
2
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.肝细胞癌肝移植候选者选择及扩展标准概述：一项综述与共识声明
Liver Transpl. 2011 Oct;17 Suppl 2:S81-9. doi: 10.1002/lt.22380.
3
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.肝细胞癌肝移植中的米兰标准：基于15年经验的循证分析
Liver Transpl. 2011 Oct;17 Suppl 2:S44-57. doi: 10.1002/lt.22365.
4
2010 International Consensus Conference on Liver Transplantation for Hepatocellular Carcinoma: texts of experts.
Liver Transpl. 2011 Oct;17 Suppl 2:S1-5. doi: 10.1002/lt.22350.
5
New strategies in hepatocellular carcinoma: genomic prognostic markers.肝细胞癌的新策略：基因组预后标志物。
Clin Cancer Res. 2010 Oct 1;16(19):4688-94. doi: 10.1158/1078-0432.CCR-09-1811. Epub 2010 Aug 16.
6
Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation.肝移植术后复发性肝细胞癌的自然病史及治疗管理
Gastroenterol Clin Biol. 2009 May;33(5):361-9. doi: 10.1016/j.gcb.2009.02.036. Epub 2009 Apr 23.
7
Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database.利用移植受者科学登记数据库重新评估肝细胞癌肝移植前的选择标准。
Hepatology. 2009 Mar;49(3):832-8. doi: 10.1002/hep.22693.
8
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.肝细胞癌肝移植：初始不符合米兰选择标准患者的降期治疗结果
Am J Transplant. 2008 Dec;8(12):2547-57. doi: 10.1111/j.1600-6143.2008.02409.x.
9
Translating evidence into practice: a model for large scale knowledge translation.将证据转化为实践：一种大规模知识转化模式。
BMJ. 2008 Oct 6;337:a1714. doi: 10.1136/bmj.a1714.
10
Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis.肝细胞癌诊断中肝脏病变活检后针道种植的系统评价与Meta分析
Gut. 2008 Nov;57(11):1592-6. doi: 10.1136/gut.2008.149062. Epub 2008 Jul 31.
Zotero 插件